RECRUITING

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Talk to us

Conditions

Pancreatic Cancerpancreasbiomarkershealth disparities

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.

Official Title

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Quick Facts

Study Start:2023-02-22
Study Completion:2026-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05687188

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Adults 18 years of age or older at time of signing informed consent
  2. * Patients who self-report as African American, Non-Hispanic White
  3. * Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor.
  1. * Patient under 18 years of age
  2. * Has no suspicion or diagnosis of a pancreatic cancer or tumor
  3. * Self-reported race/ethnicity other than African American or Non-Hispanic White.

Contacts and Locations

Principal Investigator

Jennifer Permuth, PhD, MS
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center
Mokenge Malafa, MD
PRINCIPAL_INVESTIGATOR
Moffitt Cancer Center

Study Locations (Sites)

Moffitt Cancer Center
Tampa, Florida, 33612
United States
University of Mississippi Medical Center
Jackson, Mississippi, 39216
United States

Collaborators and Investigators

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

  • Jennifer Permuth, PhD, MS, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center
  • Mokenge Malafa, MD, PRINCIPAL_INVESTIGATOR, Moffitt Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-02-22
Study Completion Date2026-12

Study Record Updates

Study Start Date2023-02-22
Study Completion Date2026-12

Terms related to this study

Keywords Provided by Researchers

  • pancreas
  • biomarkers
  • health disparities

Additional Relevant MeSH Terms

  • Pancreatic Cancer